The Fisher Funds New Zealand Growth Fund is our flagship fund and was launched in August 1998. The fund aims to produce attractive long term returns by investing in quality companies chosen by our Investment Team. Typically the fund will be invested in 15 to 20 companies in at any one time. Often a company in the fund will have been chosen because it offers a unique product or service, has a dominant market position or brand, or operates in a fast growing sector.
|Fisher & Paykel Healthcare Corporation Limited||17.6%|
|-12% Share Price Change||-1.4% Contribution to Return|
Fisher & Paykel Healthcare Corporation Limited
|5% Share Price Change||0.9% Contribution to Return|
|-3% Share Price Change||-0.5% Contribution to Return|
In the portfolio holdings below you will find a range of well loved New Zealand companies from logistics providers like Mainfreight through to dairy pioneer The a2 Milk Company.
Fisher & Paykel Healthcare (+5%) announced that sales growth accelerated further in the December quarter as COVID infections surged in many regions globally. Hospitals have reacted by preparing to treat more COVID patients, with F&P's Airvo and Optiflow nasal high flow therapy products increasingly being used as the first line of treatment for patients.
Vista (-11%) underperformed as the reacceleration of COVID in many regions pushes out the reopening of the global cinema industry. Around 55% of global cinema sites are currently open, which is less than at the end of September when around 75% of sites were open. However, the current rollout of vaccines provides comfort the industry will recover later in the year with Vista well positioned to benefit.
Is there anything we
can help you with?